Vertex Solutions, a small business known for the manufacturing of systems integration and advanced training technologies, has ...

Vertex Pharma's non-opioid painkiller suzetrigine was unable to perform better than placebo in a phase 2 trial in lumbosacral radiculopathy (LSR), a form of neuropathic back pain, ahead of an FDA ...

Vertex Securities Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 Certificate under Regulation 74 (5) of the Securities Exchange Board of India (Depositories and ...

Vertex' therapy takes the form of stem cell-derived human pancreatic islet cells, which secrete insulin in the body in response to rising blood glucose. The aim is to replace the pancreatic tissue ...

Once I decided I wanted NotebookLM to help me with the topic, I went in search of string theory content (there's a lot more ...

Zacks Research has upped the financial bar for Vertex Pharmaceuticals, boosting its 2026 earnings forecast from $16.18 to $16 ...

Reshma Kewalramani is the only person of Indian-origin to find her way to the 2025 list. Kewalramani emigrated to the United ...

Vertex Growth is a growth-stage venture capital fund anchored by Vertex Holdings, a subsidiary of global investment firm Temasek. The fund is dedicated to investing in high potential companies on the ...

Vertex Pharmaceuticals slipped 1.41% to close at $475.49, managing to outperform a much gloomier market where the S&P 500 nose-dived 3.46%. Despite the drop, Vertex flexed its resilience, outpacing ...

While Accel is negotiating a deal with Vaya and August AI, Prosus is inching closer to a deal with Arivihan. Stellaris ...